The Effectiveness of Doin (Conduction Exercise) of the Pelvic Joint for HLD With Radiating Leg Pain

The Effectiveness of Doin (Conduction Exercise) of the Pelvic Joint for Herniated Lumbar Disc (HLD) With Radiating Leg Pain: A Prospective Observational Pilot Study

A prospective pilot study will be conducted to investigate the effectiveness and safety in herniated lumbar disc (HLD) patients receiving integrative Korean medicine treatment including Doin (conduction exercise) at a Korean medicine hospital through assessment of pain, functional disability, and quality of life.

Study Overview

• Status: Completed
• Conditions: Sciatica; Intervertebral Disc Displacement; Sciatic Radiculopathy
• Intervention / Treatment: Procedure: Acupuncture; Procedure: Electroacupuncture; Procedure: Cupping; Drug: Herbal medicine; Other: Other intervention(s); Procedure: Chuna manual therapy; Procedure: Bee venom pharmacopuncture; Procedure: Pharmacopuncture; Procedure: Doin (conduction exercise)

Detailed Description

A prospective single-center observational pilot study will be conducted to investigate the effectiveness and safety in herniated lumbar disc (HLD) patients with radiating leg pain receiving integrative Korean medicine treatment including Doin (conduction exercise) of the pelvic joint at Daejeon Jaseng Hospital of Korean Medicine through assessment of pain, functional disability, quality of life, satisfaction, and safety.

The study is expected to be performed over a period of 6 months, during the former 3 months of the study period of which the Integrative Korean medicine treatment group will be recruited, and after a wash-out period of 2 weeks, during the latter 3 months of the study period of which the Doin with integrative Korean medicine will be recruited separately.

• Study Type: Observational
• Enrollment (Actual): 40

Contacts and Locations

Study Locations

• Korea, Republic of
  • Daejeon, Korea, Republic of, 35262
    • Daejeon Jaseng Hospital of Korean Medicine

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 19 years to 70 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Herniated lumbar disc (HLD) patients with radiating leg pain

Description

Inclusion Criteria:

• Inpatients with radiating leg pain distal to the gluteal fold with or without low back pain (LBP)
• Patients with onset of radiating leg pain occurrence within the last six months, and current pain intensity of numeric rating scale (NRS) ≥5
• Patients with disc protrusion or extrusion at the neural segment level with significant correlations with the radiating leg pain symptoms as identified on L-spine magnetic resonance imaging (MRI)
• Patients with plans of receiving Korean medicine treatment for herniated lumbar disc (HLD) through hospitalized care
• Patients who give voluntary written informed consent to study participation

Exclusion Criteria:

• Patients with other systemic diseases that may interfere with treatment effect or outcome interpretation
• Surgery and surgical procedure in the last three weeks in areas of clinical relevance as a result of HLD
• Patients with soft tissue pathologies or pathologies of non-spinal origin that may cause LBP or radiating leg pain (e.g. spinal tumor, rheumatoid arthritis)
• Patients for whom acupuncture treatment may be inappropriate or unsafe (e.g. hemorrhagic diseases, blood clotting disorders, history of anti-coagulation medicine intake, serious diabetes with risk of infection, severe cardiovascular diseases, or other conditions deemed unsuitable for acupuncture treatment)
• Pregnant patients or patients planning pregnancy
• Patients with serious psychological disorders
• Participating in other clinical studies other than observational studies
• Patients unable to fill out study participation consent form
• Subjects deemed unsuitable for study participation as assessed by the researchers

Study Plan

How is the study designed?

Design Details

• Observational Models: Case-Only
• Time Perspectives: Prospective

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Integrative Korean medicine treatment; Herniated lumbar disc (HLD) patients with radiating leg pain in the integrative Korean medicine treatment group will be administered integrative Korean medicine treatment consisting of 2 sessions/day of acupuncture, and herbal medicine, Chuna manual therapy, bee venom pharmacopuncture and pharmacopuncture, electroacupuncture, cupping, and other interventions, as needed.	Procedure: Acupuncture; Acupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.; Procedure: Electroacupuncture; Electroacupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.; Procedure: Cupping; Cupping treatment will be administered at 1-2 points using mainly proximal acupuncture points and Ah-shi points.; Drug: Herbal medicine; Herbal medicine will be mainly administered in water-based decoction (120ml) and dried powder (2g) form (the ingredients are mainly, but not restricted to: Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, Saposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycine max, Atractylodes japonica).; Other Names: Traditional herbal medicine; Other: Other intervention(s); Patients will be allowed any other additional intervention(s) as deemed necessary by the attending physician regardless of type or dose, and patterns of use will be investigated and recorded as an pragmatic clinical study.; Procedure: Chuna manual therapy; Chuna is a Korean spinal manipulation that incorporates spinal manipulation techniques for joint mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manipulation will be administered at the physician's discretion.; Other Names: Chuna manipulation; Chuna spinal manipulation; Procedure: Bee venom pharmacopuncture; Bee venom pharmacopuncture will be administered only after confirming a negative response to hypersensitivity skin test. Diluted bee venom (saline:bee venom ratio, 10,000:1) filtered for allergens will be injected at 4-5 acupoints proximal to the dysfunctional site at the physician's discretion. Each acupuncture point will be injected to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).; Other Names: Bee venom acupuncture; Procedure: Pharmacopuncture; Pharmacopuncture consisting of select herbal ingredients will be administered at Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).
Doin with integrative Korean medicine; Herniated lumbar disc (HLD) patients with radiating leg pain in the Doin (conduction exercise) with integrative Korean medicine treatment group will be administered integrative Korean medicine treatment consisting of 2 sessions/day of acupuncture, and herbal medicine, Chuna manual therapy, bee venom pharmacopuncture and pharmacopuncture, electroacupuncture, cupping, and other interventions, as needed, plus Doin (conduction exercise) for 1 session of the 2 sessions/day of acupuncture.	Procedure: Acupuncture; Acupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.; Procedure: Electroacupuncture; Electroacupuncture treatment will be administered using mainly proximal acupuncture points and Ah-shi points.; Procedure: Cupping; Cupping treatment will be administered at 1-2 points using mainly proximal acupuncture points and Ah-shi points.; Drug: Herbal medicine; Herbal medicine will be mainly administered in water-based decoction (120ml) and dried powder (2g) form (the ingredients are mainly, but not restricted to: Ostericum koreanum, Eucommia ulmoides, Acanthopanax sessiliflorus, Achyranthes japonica, Psoralea corylifolia, Saposhnikovia divaricata, Cibotium barometz, Lycium chinense, Boschniakia rossica, Cuscuta chinensis, Glycine max, Atractylodes japonica).; Other Names: Traditional herbal medicine; Other: Other intervention(s); Patients will be allowed any other additional intervention(s) as deemed necessary by the attending physician regardless of type or dose, and patterns of use will be investigated and recorded as an pragmatic clinical study.; Procedure: Chuna manual therapy; Chuna is a Korean spinal manipulation that incorporates spinal manipulation techniques for joint mobilization involving high-velocity, low amplitude thrusts to joints slightly beyond the passive range of motion and gentle force to joints within the passive range of movement. Chuna manipulation will be administered at the physician's discretion.; Other Names: Chuna manipulation; Chuna spinal manipulation; Procedure: Bee venom pharmacopuncture; Bee venom pharmacopuncture will be administered only after confirming a negative response to hypersensitivity skin test. Diluted bee venom (saline:bee venom ratio, 10,000:1) filtered for allergens will be injected at 4-5 acupoints proximal to the dysfunctional site at the physician's discretion. Each acupuncture point will be injected to a total of 0.5-1 cc using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).; Other Names: Bee venom acupuncture; Procedure: Pharmacopuncture; Pharmacopuncture consisting of select herbal ingredients will be administered at Ah-shi points and local acupuncture points using disposable injection needles (CPL, 1 cc, 26G x 1.5 syringe, Shinchang medical co., Korea).; Procedure: Doin (conduction exercise); An acupuncture physician will administer acupuncture at 4-8 acupoints in the low back and gluteal area (mandatory points: BL54, and GB30 ipsilateral to the dysfunctional site; and selective points: BL23, BL24, BL25, BL26, BL31, BL32, Ah-shi points, local acupuncture points and/or trigger points. Doin (conduction exercise) will be performed as active and passive movement with the needles in situ to the aim of effective treatment of pain and functional disability by increasing the hip joint range of motion (flexion and extension) with physician guidance and isometric resistance exercise (flexion and extension) as needed. Doin (conduction exercise) sessions will be performed 1 session/day for the duration of hospitalized treatment while the patient presents radiating leg pain (NRS≥1).; Other Names: Doin Exercise; Do-in Exercise; Conduction Exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Numeric Rating Scale (NRS) of low back pain	Change in low back pain intensity at 2 weeks as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'.	Baseline, 2 weeks post-baseline
Change in Numeric Rating Scale (NRS) of radiating leg pain	Change in radiating leg pain intensity at 2 weeks as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'.	Baseline, 2 weeks post-baseline
Change in Oswestry Disability Index (ODI)	Functional disability questionnaire at 2 weeks as measured using ODI. The ODI is a 10-item questionnaire developed to assess level of disability due to low back pain (LBP). Each item is graded into 6 levels, each representing a score of 0-5. Higher scores indicate greater limitation relating to LBP.	Baseline, 2 weeks post-baseline

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Numeric Rating Scale (NRS) of low back pain	Low back pain intensity as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Numeric Rating Scale (NRS) of radiating leg pain	Radiating leg pain intensity as measured using NRS. In pain measurement using NRS, patients are asked to rate their pain by selecting a number from 0 to 10 that best represents their pain severity between the anchors of 0 which indicates 'no pain', and 10 which indicates 'worst pain possible'.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Oswestry Disability Index (ODI)	Functional disability questionnaire as measured using ODI. The ODI is a 10-item questionnaire developed to assess level of disability due to low back pain (LBP). Each item is graded into 6 levels, each representing a score of 0-5. Higher scores indicate greater limitation relating to LBP.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Visual Analogue Scale (VAS) of radiating leg pain	Radiating leg pain intensity as measured using VAS. VAS uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain' and 'worst pain possible' (labels may vary by study). Scores are recorded in millimeters with a total range of 0-100 millimeters.	Baseline, 3, 7, 10, 14 days post-baseline
Visual Analogue Scale (VAS) of low back pain	Low back pain intensity as measured using VAS. VAS uses a 10cm line labeled at each end with scale anchors. In pain measurement using VAS, patients are asked to mark a point that represents their pain between the anchors of 'no pain' and 'worst pain possible' (labels may vary by study). Scores are recorded in millimeters with a total range of 0-100 millimeters.	Baseline, 3, 7, 10, 14 days post-baseline
EuroQol 5-Dimension (EQ-5D)	Health-related quality of life questionnaire as measured using SF-36. SF-36 consists of 36 items across 8 domains: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health. SF-36 is used to rate functional health and well-being in patients and healthy individuals. Higher scores indicate better HRQoL.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Patient Global Impression of Change (PGIC)	Global patient-reported outcome as measured using PGIC. PGIC grades the level of subjective improvement into 7 levels (1, very much improved; 2, much improved; 3, slightly improved; 4, no change; 5, slightly worse; 6, much worse; and 7, very much worse).	Baseline, 14, 30, 90 days post-baseline
Drug Consumption (drug type)	Regarding recent use of medication, the type of prescription intake for medicine will be recorded.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Drug Consumption (drug intake frequency)	Regarding recent use of medication, the frequency of prescription intake for medicine will be recorded.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Drug Consumption (drug intake period)	Regarding recent use of medication, the period of prescription intake for medicine will be recorded.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Use of additional medical treatment (treatment type)	Regarding current use of medical services, the type of additional medical treatment received will be recorded.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Use of additional medical treatment (treatment frequency)	Regarding current use of medical services, the frequency of additional medical treatment received will be recorded.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Use of additional medical treatment (treatment period)	Regarding current use of medical services, the period of additional medical treatment received will be recorded.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Details of Doin conduction exercise sessions (type (region))	Administration details of Doin conduction exercise session type (region) will be recorded.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Details of Doin conduction exercise sessions (period)	Administration details of Doin conduction exercise sessions (period) will be recorded.	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline
Lumbar range of movement (ROM)	Physical examination	Baseline, 3, 7, 10, 14 days post-baseline
Straight leg raise (SLR) test	Physical examination	Baseline, 3, 7, 10, 14 days post-baseline
Adverse events	Safety outcome	Baseline, 3, 7, 10, 14, 30, 90 days post-baseline

Collaborators and Investigators

• Sponsor: Jaseng Medical Foundation
• Investigators: Principal Investigator: Min-young Kim, KMD, Daejeon Jaseng Hospital of Korean Medicine

Study record dates

Study Major Dates

• Study Start (Actual): July 9, 2018
• Primary Completion (Actual): July 4, 2019
• Study Completion (Actual): September 20, 2019

Study Registration Dates

• First Submitted: June 1, 2018
• First Submitted That Met QC Criteria: June 18, 2018
• First Posted (Actual): June 27, 2018

Study Record Updates

• Last Update Posted (Actual): November 4, 2019
• Last Update Submitted That Met QC Criteria: November 1, 2019
• Last Verified: November 1, 2019

More Information

Terms related to this study

• Keywords: Exercise; Acupuncture; Complementary Therapies
• Additional Relevant MeSH Terms: Nervous System Diseases; Pain; Neurologic Manifestations; Musculoskeletal Diseases; Neuromuscular Diseases; Sciatic Neuropathy; Mononeuropathies; Peripheral Nervous System Diseases; Neuralgia; Pathological Conditions, Anatomical; Spinal Diseases; Bone Diseases; Hernia; Sciatica; Intervertebral Disc Displacement; Radiculopathy
• Other Study ID Numbers: JS-CT-2018-02

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No